HUMIRA 40 MG/0.8 ML SYRINGE

Adalimumab
$3373.6300per EA

Manufacturer

AbbVie Inc.

NDC

00074379902

Classification

Brand

Dosage Form

KIT

Last Updated

4/22/2026

Approval Type

Biologic (BLA)

FDA Application

BLA125057

On Market Since

12/31/2002

Price History

1W

0.0%

1M

-0.0%

3M

+0.1%

6M

+0.3%

1Y

+0.4%

3Y

+0.1%

5Y

+16.1%

All

+195.6%

Generic Alternatives

Save up to 0%

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.